New Complementary Medicine Guidelines Available From Society of Integrative Oncology

Publication
Article
OncologyONCOLOGY Vol 21 No 9
Volume 21
Issue 9

The Society for Integrative Oncology (SIO), an international organization established in 2003 to encourage scientific evaluation, dissemination of evidence-based information, and appropriate clinical integration of complementary therapies, recently issued practice guidelines regarding the use of nonconventional treatment modalities

The Society for Integrative Oncology (SIO), an international organization established in 2003 to encourage scientific evaluation, dissemination of evidence-based information, and appropriate clinical integration of complementary therapies, recently issued practice guidelines regarding the use of nonconventional treatment modalities. The guidelines offer recommendations regarding mind-body modalities, manipulative and body-based practices, energy therapies, acupuncture, botanicals, vitamins, and other supplements.

As noted in the Executive Summary of the guidelines,

Health care professionals should be able to provide evidence-based, patient-centered advice to guide patients to receive benefit while avoiding harm. A panel of experts in oncology and integrative medicine was assembled to evaluate the current level of evidence regarding complementary therapies relevant to the care of cancer patients. Specific recommendations are made based on the strength of evidence and the risks/benefit ratio.

Published in the spring issue of the Journal of the Society of Integrative Oncology (5[2]:65-84, 2007), the guidelines were written by Gary E. Deng, Barry R. Cassileth, Lorenzo Cohen, Jyothirmai Gubili, Peter A.S. Johnstone, Nagi Kumar, and Andrew Vickers, and approved by the SIO's Executive Committee, which includes Donald Abrams, Lorenzo Cohen, Peter A.S. Johnstone, David Rosenthal, Stephen Sagar, and Dibu Tripathy.

The SIO guidelines emphasize the distinction between "complementary" and "alternative" therapies. Complementary therapies, note the SIO authors, are supportive measures used as adjuncts to mainstream care. Alternative therapies are scientifically unproven and are used instead of mainstream treatment or offered as viable therapeutic options instead of mainstream care."

A work in progress, the guidelines will be updated as needed and are also available on the SIO website at www.IntegrativeOnc.org.

Recent Videos
Providing easier access to ancillary services for patients with PDAC who live farther away from the treatment center may help them complete the treatment regimen.
Future research will aim to assess the efficacy of PIPAC-MMC plus systemic therapy vs systemic therapy alone in patients with peritoneal tumors.
Although small incision surgery may serve as a conduit to deliver PIPAC-MMC, it may confer benefits in the staging and treatment of peritoneal tumors.
Patients with peritoneal metastases were historically associated with limited survival and low consideration for clinical trials.
Greater cancer treatment longevity enables oncologists the ability to form more impactful relationships with their patients.
3 experts are featured in this series.
3 experts are featured in this series.
Related Content